Polarization  	Polarization  	 NNP	B-NP
of  	of  	 IN	O
human  	human  	 JJ	O
monocyte-derived  	monocyte-derived  	 JJ	B-NP
dendritic  	dendritic  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
to  	to  	 TO	O
DC1  	DC1  	 CD	B-NP
by  	by  	 IN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
stimulation  	stimulation  	 NN	I-NP
with  	with  	 IN	O
Newcastle  	Newcastle  	 NNP	B-NP
Disease  	Disease  	 NNP	I-NP
Virus  	Virus  	 NNP	I-NP
Dendritic  	Dendritic  	 NNP	I-NP
cell  	cell  	 NN	I-NP
( 	( 	 -LRB-	I-NP
DC 	DC 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
-based  	-based  	 JJ	I-NP
tumor  	tumor  	 NN	I-NP
vaccines  	vaccines  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
tested  	tested  	 VBN	O
extensively  	extensively  	 RB	O
to  	to  	 TO	O
treat  	treat  	 VB	O
cancer  	cancer  	 NN	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
several  	several  	 JJ	O
DC-based  	DC-based  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
trials  	trials  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
disappointing 	disappointing 	 JJ	O
.  	.  	 .	O
Amelioration  	Amelioration  	 NNP	B-NP
of  	of  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
modality  	modality  	 NN	B-NP
for  	for  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
treatment  	treatment  	 NN	I-NP
seems  	seems  	 VBZ	O
warranted 	warranted 	 VBN	O
,  	,  	 ,	O
i.e.  	i.e.  	 FW	O
by  	by  	 IN	O
improving  	improving  	 VBG	B-NP
DC  	DC  	 NNP	I-NP
immunogenicity  	immunogenicity  	 NN	I-NP
and  	and  	 CC	O
polarization 	polarization 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
potential  	potential  	 NN	O
for  	for  	 IN	O
immune  	immune  	 JJ	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	O
human  	human  	 JJ	O
DCs  	DCs  	 NN	B-NP
by  	by  	 IN	O
incubating  	incubating  	 VBG	O
them  	them  	 PRP	O
in  	in  	 IN	O
vitro  	vitro  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
Newcastle  	Newcastle  	 NNP	B-NP
Disease  	Disease  	 NNP	I-NP
Virus  	Virus  	 NNP	I-NP
( 	( 	 -LRB-	O
NDV 	NDV 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
paramyxovirus  	paramyxovirus  	 NN	B-NP
with  	with  	 IN	O
strong  	strong  	 JJ	O
immunostimulatory  	immunostimulatory  	 JJ	B-NP
properties 	properties 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
vitro  	vitro  	 JJ	B-NP
infection  	infection  	 NN	I-NP
with  	with  	 IN	O
NDV  	NDV  	 NNP	B-NP
of  	of  	 IN	O
human  	human  	 JJ	O
monocyte-derived  	monocyte-derived  	 JJ	B-NP
DCs--generated  	DCs--generated  	 NN	I-NP
from  	from  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
monocytes  	monocytes  	 JJ	I-NP
cultured  	cultured  	 NN	I-NP
with  	with  	 IN	O
IL-4  	IL-4  	 NN	B-NP
and  	and  	 CC	O
GM-CSF--induces  	GM-CSF--induces  	 JJ	B-NP
the  	the  	 DT	O
generation  	generation  	 NN	O
of  	of  	 IN	O
viral  	viral  	 JJ	O
M  	M  	 NNP	O
gene  	gene  	 NN	B-NP
transcripts  	transcripts  	 NNS	I-NP
and  	and  	 CC	O
RIG-I  	RIG-I  	 JJ	B-NP
expression  	expression  	 NN	I-NP
within  	within  	 IN	O
DCs 	DCs 	 JJ	O
.  	.  	 .	O
Expression  	Expression  	 NN	O
of  	of  	 IN	O
both  	both  	 DT	O
genes  	genes  	 NNS	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
upon  	upon  	 IN	O
co-stimulation  	co-stimulation  	 JJ	B-NP
with  	with  	 IN	O
LPS 	LPS 	 NNP	B-NP
.  	.  	 .	O
Surprisingly 	Surprisingly 	 RB	O
,  	,  	 ,	O
LPS  	LPS  	 NNP	B-NP
and  	and  	 CC	O
NDV  	NDV  	 NNP	B-NP
had  	had  	 VBD	O
opposite  	opposite  	 JJ	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
induction  	induction  	 NN	B-NP
of  	of  	 IN	I-NP
interferon  	interferon  	 NNS	I-NP
( 	( 	 -LRB-	I-NP
IFN 	IFN 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
-alpha 	-alpha 	 JJ	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
NDV  	NDV  	 FW	B-NP
induced  	induced  	 FW	I-NP
DC  	DC  	 FW	I-NP
maturation  	maturation  	 FW	I-NP
( 	( 	 -LRB-	O
as  	as  	 RB	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
TNF-alpha  	TNF-alpha  	 JJ	B-NP
production  	production  	 NN	I-NP
and  	and  	 CC	O
CD80  	CD80  	 CD	B-NP
cell  	cell  	 NN	I-NP
surface  	surface  	 NN	I-NP
expression 	expression 	 NN	I-NP
)  	)  	 -RRB-	O
only  	only  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
LPS 	LPS 	 NNP	B-NP
.  	.  	 .	O
Most  	Most  	 RBS	O
interestingly 	interestingly 	 RB	O
,  	,  	 ,	O
an  	an  	 DT	O
optimal  	optimal  	 JJ	B-NP
combination  	combination  	 NN	I-NP
of  	of  	 IN	I-NP
NDV  	NDV  	 NNP	I-NP
and  	and  	 CC	O
LPS  	LPS  	 NNP	B-NP
caused  	caused  	 VBD	I-NP
polarization  	polarization  	 VBN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
DCs  	DCs  	 JJ	O
to  	to  	 TO	O
Th1  	Th1  	 CD	B-NP
type  	type  	 NN	I-NP
cytokines  	cytokines  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
high  	high  	 JJ	O
ratio  	ratio  	 NN	O
of  	of  	 IN	O
interleukin  	interleukin  	 NNS	B-NP
( 	( 	 -LRB-	O
IL 	IL 	 NNP	B-NP
) 	) 	 -RRB-	O
-12  	-12  	 CD	O
to  	to  	 TO	O
IL-10 	IL-10 	 CD	B-NP
.  	.  	 .	O
These  	These  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
results  	results  	 NNS	I-NP
provide  	provide  	 VBP	O
a  	a  	 DT	O
means  	means  	 NNS	O
and  	and  	 CC	O
protocol  	protocol  	 NN	O
for  	for  	 IN	O
maturation  	maturation  	 NN	B-NP
and  	and  	 CC	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	O
DCs  	DCs  	 JJ	O
with  	with  	 IN	O
enhanced  	enhanced  	 JJ	O
and  	and  	 CC	O
sustained  	sustained  	 JJ	O
T  	T  	 NN	B-NP
helper  	helper  	 NN	I-NP
type  	type  	 NN	I-NP
1-polarizing  	1-polarizing  	 CD	O
capacity 	capacity 	 NN	O
.  	.  	 .	O
Such  	Such  	 JJ	O
pretreated  	pretreated  	 JJ	B-NP
DCs  	DCs  	 NN	I-NP
may  	may  	 MD	O
significantly  	significantly  	 RB	O
improve  	improve  	 VB	O
DC-based  	DC-based  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
immunotherapy 	immunotherapy 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
encourage  	encourage  	 VBP	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
RNA-based  	RNA-based  	 JJ	B-NP
viral  	viral  	 JJ	I-NP
vectors  	vectors  	 NN	I-NP
as  	as  	 IN	O
potential  	potential  	 JJ	B-NP
novel  	novel  	 NN	I-NP
and  	and  	 CC	O
powerful  	powerful  	 JJ	O
gene  	gene  	 NN	B-NP
transfer  	transfer  	 NN	I-NP
modality  	modality  	 NN	I-NP
for  	for  	 IN	I-NP
cytoplasmic  	cytoplasmic  	 JJ	I-NP
gene  	gene  	 NN	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
professional  	professional  	 JJ	B-NP
antigen-presenting  	antigen-presenting  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
APC 	APC 	 NNP	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
overcome  	overcome  	 VB	O
immunosuppression  	immunosuppression  	 VBN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
